Pfizer said Thursday its drug Ibrance showed efficacy in a group of breast cancer patients who do not currently have access ...

I just returned from San Diego and the annual meeting of the American Society of Hematology, where Arcellx won the battle of ...

Stoke Therapeutics is nearing FDA sign-off on a groundbreaking Phase 3 clinical trial for its experimental drug for Dravet ...

Akshara Ramasamy will soon begin medical school in Texas — but the state’s new requirement to ask hospital patients about ...

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. ...

As health insurers use AI to deny more claims, startups are turning to AI to make it easier to appeal denials, which often go ...

Shaped by his own addiction, Robert F. Kennedy Jr. is embracing ideologically flexible approaches to the opioid epidemic.

"Our policies are saving lives,” Biden officials say about the drop in drug overdose deaths. Experts say that may not be the ...

A proposed Senate bill that would prohibit companies that control health insurers or pharmacy benefit managers from owning ...

A health insurance company executive turned whistleblower, Wendell Potter thinks that the backlash to the industry is missing ...

Investigators trying to determine how a child in California might have contracted bird flu are continuing to learn more ...

Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.